These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3369099)

  • 1. [Methylprednisolone in pulsed doses in chronic glomerulopathies and in nephrotic syndrome with minimal change].
    Matousovic K; Prát V; Kuzemová L; Zástava V
    Vnitr Lek; 1988 Mar; 34(3):262-9. PubMed ID: 3369099
    [No Abstract]   [Full Text] [Related]  

  • 2. Seizures and transient blindness following intravenous pulse methylprednisolone in children with primary glomerulonephritis.
    Bettinelli A; Paterlini G; Mazzucchi E; Giani M
    Child Nephrol Urol; 1991; 11(1):41-3. PubMed ID: 1868481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of kidney diseases with massive doses of methylprednisolone].
    Kal'tianis PA
    Pediatriia; 1985 Jun; (6):69-72. PubMed ID: 3898009
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of chronic glomerulonephritis with imuran].
    Kämpfen P; Hodler J
    Schweiz Med Wochenschr; 1970 Dec; 100(49):2093-100. PubMed ID: 5495326
    [No Abstract]   [Full Text] [Related]  

  • 5. [Differentiated pathogenetic therapy of glomerulonephritis].
    Belovezhdov N
    Ter Arkh; 1987; 59(8):38-40. PubMed ID: 3686444
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cyclosporin A in glomerular diseases].
    Brodehl J
    Internist (Berl); 1985 Sep; 26(9):578-9. PubMed ID: 3905681
    [No Abstract]   [Full Text] [Related]  

  • 7. [Efficacy and problems of the pulse therapy and alternate-day schedule].
    Miyawaki S; Hashimoto K; Ofuji T
    Nihon Rinsho; 1984 Nov; 42(11):2509-15. PubMed ID: 6397616
    [No Abstract]   [Full Text] [Related]  

  • 8. Macrohematuria with electron-dense deposits in a 14-year-old boy with minimal change nephrotic syndrome.
    Filler G; Robb I; Carpenter B
    Pediatr Nephrol; 2001 Jan; 16(1):91-3; discussion 94-6. PubMed ID: 11198614
    [No Abstract]   [Full Text] [Related]  

  • 9. Autoimmune thyroiditis and vitiligo in a child with minimal change nephrotic syndrome.
    Kuzmanovska DB; Shahpazova EM; Kocova MJ; Gruevska SJ; Petrushevska G
    Pediatr Nephrol; 2001 Dec; 16(12):1137-8. PubMed ID: 11793116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Minimal change nephrotic syndrome].
    Hirayama K; Kobayashi M
    Nihon Jinzo Gakkai Shi; 2010; 52(7):882-7. PubMed ID: 21077335
    [No Abstract]   [Full Text] [Related]  

  • 11. [Indomethacin in the treatment of glomerulonephritis].
    Tomilina NA; Biriukova LS
    Sov Med; 1983; (9):104-6. PubMed ID: 6648668
    [No Abstract]   [Full Text] [Related]  

  • 12. [Squamous cell lung cancer with minimal-change nephrotic syndrome].
    Yamagata T; Akamatsu K; Kuroda M; Yamagata Y; Nisimoto T; Nakanishi H; Habu Y; Ikeda T; Mimura K; Yukawa S
    Nihon Kokyuki Gakkai Zasshi; 1998 Dec; 36(12):1032-7. PubMed ID: 10064957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current therapeutic possibilities in chronic idiopathic glomerulonephritis].
    Ponticelli C; Fogazzi GB
    Minerva Urol Nefrol; 1985; 37(1):9-12. PubMed ID: 3901338
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization and significance of urinary fibrin degradation products.
    Cortes P; Potter EV; Kwaan HC
    J Lab Clin Med; 1973 Sep; 82(3):377-89. PubMed ID: 4199524
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of long-term azathioprine administration in adults with minimal-change glomerulonephritis and nephrotic syndrome resistant to corticosteroids.
    Cade R; Mars D; Privette M; Thompson R; Croker B; Peterson J; Campbell K
    Arch Intern Med; 1986 Apr; 146(4):737-41. PubMed ID: 3963956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus statement on management of steroid sensitive nephrotic syndrome.
    Indian Pediatric Nephrology Group, Indian Academy of Pediatrics
    Indian Pediatr; 2001 Sep; 38(9):975-86. PubMed ID: 11568373
    [No Abstract]   [Full Text] [Related]  

  • 17. Elevated vascular endothelial growth factor levels in the urine of patients with minimal-change nephrotic syndrome.
    Matsumoto K; Kanmatsuse K
    Clin Nephrol; 2001 Apr; 55(4):269-74. PubMed ID: 11334311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytostatic treatment of the steroid-resistant nephrotic syndrome. (Long term study on 24 patients)].
    Oechslen D; Kluthe R; Sarre H
    Arch Klin Med; 1968; 215(2):150-60. PubMed ID: 5718136
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of diffuse proliferative lupus nephritis by intravenous high-dose methylprednisolone.
    Ponticelli C; Zucchelli P; Banfi G; Cagnoli L; Scalia P; Pasquali S; Imbasciati E
    Q J Med; 1982; 51(201):16-24. PubMed ID: 7111671
    [No Abstract]   [Full Text] [Related]  

  • 20. T cell subsets in glomerulonephritis.
    Lin CY; Yang YM; Fu YK
    Int J Pediatr Nephrol; 1986; 7(2):63-8. PubMed ID: 3487514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.